A small phase 1 trial of the investigational VERVE-102 gene-editing approach lowered LDL (“bad”) cholesterol after a single infusion. But it hasn’t been shown to prevent heart attacks or strokes, so it’s not a reason to stop proven cholesterol medicines.
Starting July 1, 2026, Medicare’s temporary GLP-1 Bridge may help some beneficiaries with obesity and prior cardiovascular disease get certain GLP-1 drugs for a flat $50 a month. But if Wegovy is prescribed for its FDA-approved cardiovascular-risk-reduction use, CMS says that claim generally belongs in regular Part D instead of the Bridge.
A March 2026 multisociety guideline says some adults may need earlier cholesterol risk review, one-time Lp(a) testing, and more personalized prevention decisions.
Home blood pressure monitoring is more than a convenience. Done with the right cuff and technique, it can reveal patterns, reduce misleading one-time readings, and help people and clinicians track hypertension more accurately. It also helps explain when a high reading needs urgent care.
The American Heart Association’s new dyslipidemia guidance puts lipoprotein(a), or Lp(a), on more clinicians’ radar. For many adults, the test is meant to refine heart-risk assessment — not replace a standard cholesterol panel or by itself tell you whether you need treatment. That matters because Lp(a) is usually inherited, often does not cause symptoms, and is not checked on routine cholesterol tests. The new guidance says a one-time measurement may help identify people whose risk is higher than their usual LDL cholesterol result suggests.
Walking getting slower or more uncomfortable? Peripheral artery disease can limit mobility even without classic calf pain, especially with vascular risks.
A randomized trial in community health centers found that team-based support plus home blood pressure checks improved systolic pressure more than enhanced usual care.
A new U.S. cholesterol guideline adds more emphasis to one-time lipoprotein(a) testing. Here’s who may want to ask and what the result can mean.
The 2025-2030 U.S. Dietary Guidelines put more weight on whole foods and less on added sugar and heavily processed foods. Here’s what changed.
A new trial found less clinically important bleeding with apixaban than rivaroxaban after a serious clot, but treatment changes still need a clinician.
Two February 2026 cholesterol headlines show how to judge study design, real outcomes, and official guidance before changing a medicine or screening plan.
A new U.S. cholesterol guideline says some adults may need risk discussions earlier, including one-time lipoprotein(a) testing and, in select cases, treatment decisions before age 40.
Heart disease remains the leading cause of death in the United States, and major health organizations now recognize chronic psychological stress as a meaningful cardiovascular risk factor. Here’s what the evidence shows, who is most vulnerable, and what practical steps can lower stress-related heart risk.
Most of the United States moved clocks forward on March 8, 2026, losing an hour of sleep. Research suggests that even this small shift can temporarily affect heart health, mood, driving safety, and workplace injuries—especially in a nation already short on sleep.
Leg pain with walking that improves with rest can be a sign of peripheral artery disease (PAD), a common and underdiagnosed condition linked to heart attack and stroke risk. Here’s what U.S. readers should know about symptoms, diagnosis, treatment, and when to seek urgent care.
Recent CDC and NCHS data show that millions of U.S. adults have hypertension and that control rates remain below national goals. Here’s what “controlled” blood pressure means, who is most affected, and what practical steps can help lower your risk.
A large randomized trial found that semaglutide reduced heart attacks and strokes in adults with overweight or obesity and established cardiovascular disease who did not have diabetes. Here’s what the evidence shows, what the FDA approval means, and what U.S. patients should know about safety, cost, and coverage.
If an adult suddenly collapses and isn’t breathing normally, call 911 and start chest compressions immediately. Here’s what current U.S. guidance says about hands-only CPR, when to use it, and how early action can save lives.
Updated recommendations from the U.S. Preventive Services Task Force emphasize screening, counseling, and preventive medications in primary care to reduce the risk of heart disease and type 2 diabetes.
U.S. health agencies continue to advise limiting added sugars to protect heart, metabolic, and oral health. Here’s what the evidence shows, how much is recommended, and practical ways to cut back without extreme dieting.
Deep vein thrombosis (DVT) can start in the legs and become life-threatening if a clot travels to the lungs. Here’s what U.S. health authorities say about symptoms, risk factors, prevention, and when to seek care.
Blood clots can be lifesaving—or dangerous. Here’s what current U.S. public health guidance and recent research say about who is at risk, warning signs to watch for, and how prevention works.
End of content
End of content